What is Angela Vediz's NPI number?

Angela Vediz's National Provider Identifier (NPI) is 1629066659, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Angela Vediz's specialty?

Angela Vediz is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).

Where is Angela Vediz located?

Angela Vediz's practice location on file with NPPES is 2829 S Jackson Ave, Joplin, MO 64804-2525.

What is Angela Vediz's phone number?

The practice phone number listed in the NPPES registry for Angela Vediz is (417) 624-0440.

Does Angela Vediz accept Medicare?

Angela Vediz is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Angela Vediz's NPI active?

Yes — Angela Vediz's NPI (1629066659) is active in the NPPES registry as of the last update on 2017-08-08.

IndividualActiveAccepts Medicare

Angela Vediz, PAC

NPI 1629066659 · Physician Assistant · Joplin, MO

Angela Vediz, PAC is a Physician Assistant provider in Joplin, MO (NPI 1629066659).

Provider details

NPI number: 1629066659
Entity type: Individual
Primary specialty: Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
Credential: PAC
Sex: Female
Sole proprietor: No
License: 2003002304 (MO)

Practice location

2829 S Jackson Ave

Joplin, MO 64804-2525

Phone: (417) 624-0440

Fax: (417) 624-9652

Street-level locationGet directions

More MO providers

Mailing address

2829 S Jackson Ave

Joplin, MO 64804-2525

Specialties & taxonomies

Physician AssistantPrimary363A00000XLicense 2003002304 (MO)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
5,919 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,140	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,610	$73
Destruction of Precancer Skin Growth, 1 Growth17000	755	$40
Destruction of Skin Growth, 1-14 Growths17110	588	$86
Biopsy of Related Skin Growth, First Growth11102	192	$67
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Doxycycline Hyclate	178	59
Triamcinolone Acetonide	129	101
Clobetasol Propionate	98	52
Nystatin	75	28
Hydroxyzine Hcl	73	27
Fluorouracil	73	69
Methotrexate Sodiumbrand: Methotrexate	70	13
Spironolactone

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,329 across 73 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-10-13
Last updated: 2017-08-08

Frequently asked questions

What is Angela Vediz's NPI number?: Angela Vediz's National Provider Identifier (NPI) is 1629066659, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Angela Vediz's specialty?: Angela Vediz is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
Where is Angela Vediz located?: Angela Vediz's practice location on file with NPPES is 2829 S Jackson Ave, Joplin, MO 64804-2525.
What is Angela Vediz's phone number?: The practice phone number listed in the NPPES registry for Angela Vediz is (417) 624-0440.
Does Angela Vediz accept Medicare?: Angela Vediz is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Angela Vediz's NPI active?: Yes — Angela Vediz's NPI (1629066659) is active in the NPPES registry as of the last update on 2017-08-08.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,140	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,610	$73
Destruction of Precancer Skin Growth, 1 Growth17000	755	$40
Destruction of Skin Growth, 1-14 Growths17110	588	$86
Biopsy of Related Skin Growth, First Growth11102	192	$67
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S

Drug

Part D claims (2024)

Beneficiaries

Doxycycline Hyclate

178

Triamcinolone Acetonide

129

101

Clobetasol Propionate

Nystatin

Hydroxyzine Hcl

Fluorouracil

Methotrexate Sodiumbrand: Methotrexate

Spironolactone

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,329 across 73 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments